Literature DB >> 12503530

Solid-state characterization of fluconazole.

Khouloud A Alkhamis1, Aiman A Obaidat, Adi F Nuseirat.   

Abstract

Two polymorphs and three solvates of fluconazole were isolated and characterized by x-ray powder diffractometry, IR spectroscopy, differential scanning calorimetry (DSC), thermogravimetry, and their dissolution rates. The different forms were prepared by crystallization of the original powder in different solvents at different cooling rates. X-ray diffraction patterns of the five solid modifications exhibited substantial differences in both the intensity and position of the peaks. FTIR spectra of the five different solid-state modifications also exhibited differences in the peaks' positions and intensities. DSC thermogram of anhydrate form I showed a single melting point at 139.2 degrees C. Anhydrate form II showed two endothermic peaks at 136.5 and 139.2 degrees C and one exothermic peak in between. The DSC thermogram of acetone 1/4 solvate exhibited two endothermic peaks at 75.5 and 139.2 degrees C. Benzene 1/7 solvate exhibited two endothermic peaks at 131.5 and 138.8 degrees C. Hydrate E exhibited two endothermic peaks at 102.7 and 139.2 degrees C. The DSC thermogram of anhydrate form II showed that this form is sensitive to the application of a mechanical force. The solubility study showed that anhydrate form II and acetone 1/4 solvate have higher solubilities than anhydrate form I while benzene 1/7 solvate and monohydrate have lower solubilities than anhydrate form I. The intrinsic dissolution study confirmed these results.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12503530     DOI: 10.1081/pdt-120015052

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  8 in total

1.  Estimating the Aqueous Solubility of Pharmaceutical Hydrates.

Authors:  Stephen J Franklin; Usir S Younis; Paul B Myrdal
Journal:  J Pharm Sci       Date:  2016-06       Impact factor: 3.534

2.  Novel olive oil phenolic (-)-oleocanthal (+)-xylitol-based solid dispersion formulations with potent oral anti-breast cancer activities.

Authors:  Mohammed H Qusa; Abu Bakar Siddique; Sami Nazzal; Khalid A El Sayed
Journal:  Int J Pharm       Date:  2019-08-05       Impact factor: 5.875

3.  Solid-state characterization and impurities determination of fluconazol generic products marketed in Morocco.

Authors:  Houda Bourichi; Youness Brik; Philipe Hubert; Yahia Cherrah; Abdelaziz Bouklouze
Journal:  J Pharm Anal       Date:  2012-08-17

4.  SBA15-Fluconazole as a Protective Approach Against Mild Steel Corrosion: Synthesis, Characterization, and Computational Studies.

Authors:  Victoria Bustos-Terrones; Iris N Serratos; Rubicelia Vargas; Bruno C Landeros-Rivera; Yaneth A Bustos-Terrones; Ana M Soto Estrada; Jonathan O Vicente Escobar; Mario A Romero Romo; Jorge Uruchurtu; Carmina Menchaca; Juan M Esparza Schulz; Armando Domínguez
Journal:  ChemistryOpen       Date:  2018-11-28       Impact factor: 2.911

5.  In Silico Prediction of Plasma Concentrations of Fluconazole Capsules with Different Dissolution Profiles and Bioequivalence Study Using Population Simulation.

Authors:  Marcelo Dutra Duque; Daniela Amaral Silva; Michele Georges Issa; Valentina Porta; Raimar Löbenberg; Humberto Gomes Ferraz
Journal:  Pharmaceutics       Date:  2019-05-05       Impact factor: 6.321

6.  Stabilisation and Growth of Metastable Form II of Fluconazole in Amorphous Solid Dispersions.

Authors:  Maciej Nowak; Maciej Gajda; Przemysław Baranowski; Patrycja Szymczyk; Bożena Karolewicz; Karol P Nartowski
Journal:  Pharmaceutics       Date:  2019-12-20       Impact factor: 6.321

7.  Insight into the Inclusion Complexation of Fluconazole with Sulfonatocalix[4]naphthalene in Aqueous Solution, Solid-State, and Its Antimycotic Activity.

Authors:  Tayel A Al Hujran; Mousa K Magharbeh; Almeqdad Y Habashneh; Rasha S Al-Dmour; Ashraf Aboelela; Hesham M Tawfeek
Journal:  Molecules       Date:  2022-07-11       Impact factor: 4.927

8.  New Approach to Antifungal Activity of Fluconazole Incorporated into the Porous 6-Anhydro-α-l-Galacto-β-d-Galactan Structures Modified with Nanohydroxyapatite for Chronic-Wound Treatments-In Vitro Evaluation.

Authors:  Justyna Rewak-Soroczynska; Paulina Sobierajska; Sara Targonska; Agata Piecuch; Lukasz Grosman; Jaroslaw Rachuna; Slawomir Wasik; Michal Arabski; Rafal Ogorek; Rafal J Wiglusz
Journal:  Int J Mol Sci       Date:  2021-03-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.